NCT06311461 Effects of Acupuncture on Symptoms of Stable Angina
| NCT ID | NCT06311461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Angina, Stable |
| Study Type | INTERVENTIONAL |
| Enrollment | 112 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 112 participants in total. It began in 2024-04-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina. This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women and men with angina, targeting additional angina burden borne of social disadvantage Participants will be randomized to a 10-acupuncture session protocol, two treatments per week for five weeks, or an attention control group. Participants will view designated, non-pain related Technology, Entertainment, Design Talks equal to the time spent receiving acupuncture (\~7.5-10 hrs.). The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body) * Treated with medical therapy for at least 1 month * Experiencing symptoms at least once per week * Speak and read English * 21 years of age minimum Exclusion Criteria: * Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy * Physical or cognitive limitations that will prevent informed consent or completion of study tasks * Use of steroid or prescription analgesic medications * Concomitant biofeedback, professional massage and acupuncture.
Contact & Investigator
Holli A. DeVon, PhD
PRINCIPAL INVESTIGATOR
University of California, Los Angeles
Frequently Asked Questions
Who can join the NCT06311461 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Angina, Stable. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06311461 currently recruiting?
Yes, NCT06311461 is actively recruiting participants. Contact the research team at hdevon@sonnet.ucla.edu for enrollment information.
Where is the NCT06311461 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06311461 clinical trial?
NCT06311461 is sponsored by University of California, Los Angeles. The principal investigator is Holli A. DeVon, PhD at University of California, Los Angeles. The trial plans to enroll 112 participants.